Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 5, 2023

Clinical Characteristics of Kawasaki Disease Combined with Liver Function Impairment in Children

Download as PDF

DOI: 10.23977/medsc.2023.040504 | Downloads: 19 | Views: 338

Author(s)

Lv Pengfei 1

Affiliation(s)

1 Hubei College of Chinese Medicine, Jingzhou, Hubei, China

Corresponding Author

Lv Pengfei

ABSTRACT

This article discusses the clinical features of Kawasaki disease in children with concurrent liver dysfunction and analyzes possible causes. Forty cases of Kawasaki disease in children with liver dysfunction and 36 cases of Kawasaki disease in children without liver dysfunction from a certain hospital between 2021 and 2022 were selected as the research subjects. Liver function indicators, electrocardiographic indicators, and treatment strategies were compared between the two groups of children. The study found that children with Kawasaki disease and concurrent liver dysfunction had significantly higher levels of ALT, AST, and TBIL, and significantly lower levels of ALB. The study suggests that children with Kawasaki disease and concurrent liver dysfunction have clinical features of elevated levels of ALT, AST, and TBIL, and the main treatment methods are immunoglobulin and hepatoprotective drugs. The etiology of this condition may be related to liver cell damage caused by immune reactions and oxidative stress, among other factors.

KEYWORDS

Kawasaki disease; Liver function damage; Clinical characteristics; Treatment plan

CITE THIS PAPER

Lv Pengfei, Clinical Characteristics of Kawasaki Disease Combined with Liver Function Impairment in Children. MEDS Clinical Medicine (2023) Vol. 4: 26-30. DOI: http://dx.doi.org/10.23977/medsc.2023.040504.

REFERENCES

[1] Huang Rui, Zhao Hongying, Tang Ying, Yang Xianqiu, Yang Fanglin, Chen Ling. Platelets and interferon in children with immunoglobulin unresponsive and sensitive Kawasaki disease- γ The expression levels of interleukin-6 and its clinical significance [J]. Journal of Guangxi Medical University, 2023, 40 (04): 670-675.
[2] Liu Lei, Song Xiaoxiang, Yu Minyi, Feng Qihua. Risk factors for drug resistance in early use of intravenous immunoglobulin therapy for Kawasaki disease [J]. Anhui Medical Journal, 2023, 27 (05): 1022-1026.
[3] Shu Zhongyu, Deng Fang. Analysis of influencing factors of Kawasaki disease with liver function damage [J]. Chinese Journal of General Medicine, 2023, 21 (04): 622-625.
[4] Yu Xiaoteng. Kawasaki disease with unilateral knee joint pain: a case report and literature review [J]. Heilongjiang Medical Journal, 2023, 47 (06): 689-691.
[5] Fang Ying, Song Qingqing, Liu Ting. Analysis of the current situation and influencing factors of delayed medical treatment for children with Kawasaki disease [J]. Nursing Practice and Research, 2023, 20 (05): 665-668.
[6] Wu Xin, Gao Hangqing, Zhao Yangyang, Jia Xulin, Liu Fei. The relationship between the expression level of oxidized high-density lipoprotein and coronary artery damage in children with Kawasaki disease [J]. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2023, 21 (05): 900-903.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4553
Visits: 196985

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.